yingweiwo

Ser Thr Protease

Ser Thr Protease

Serine (Ser) proteases are enzymes that catalyze the hydrolysis of specific peptide bonds in their substrates, and one of the amino acids in the enzyme's active site is always a serine. The trypsin family and the subtilisin family are two families that have received particular attention in research. The process of blood clotting, protein digestion, cell signaling, inflammation, and protein processing are just a few of the numerous cellular and extracellular functions that serine proteases are essential for. A threonine residue is present in the active site of a family of proteolytic enzymes known as thronine (Thr) proteases. Although the catalytic subunits of the proteasome are the prototype members of this class of enzymes, the active site geometry and mechanism of acyltransferases were convergently evolved.

Ser Thr Protease related products

Structure Cat No. Product Name CAS No. Product Description
Dansyl-Glu-Gly-Arg-Chloromethylketone V71894 Dansyl-Glu-Gly-Arg-Chloromethylketone 69024-84-6 Dansyl-Glu-Gly-Arg-Chloromethylketone is a protease inhibitor that can suppress serine/threonine proteases.
DCLK1-IN-2 V71911 DCLK1-IN-2 2978517-43-8 DCLK1-IN-2 (compound I-5) is a potent inhibitor of DCLK1 with IC50 of 171.3 nM.
DCLK1-IN-3 V84473 DCLK1-IN-3
DCLK1-IN-4 V84481 DCLK1-IN-4
Dim16 V71876 Dim16 2743448-32-8 Dim16 is a dual PCSK9/HMG-CoAR inhibitor (antagonist) with IC50 of 19 nM for PCSK9.
Ebronucimab (AK102) V71861 Ebronucimab (AK102) 2304800-90-4 Ebronucimab (AK102) is an IgG1-λ2 antibody targeting PCSK9 and is primarily expressed by CHO DG44 (Chinese Hamster Ovary) cells.
Endoproteinase Glu-C (V8 protease; Glu-C) V71891 Endoproteinase Glu-C (V8 protease; Glu-C) 137010-42-5 Endoproteinase GluC (V8 protease) is a serine protease.
Enlicitide chloride (MK-0616) V83229 Enlicitide chloride (MK-0616) 2407527-16-4 Enlicitide chloride (MK-0616) is a novel and orally bioactive cyclic peptide-based PCSK9 inhibitor
Enteropeptidase (TMPRSS15) V71912 Enteropeptidase (TMPRSS15) 9014-74-8 Enteropeptidase (TMPRSS15) is a type II transmembrane serine protease and a physiological activator of trypsinogen.
Feniralstat V71866 Feniralstat 2166320-76-7 Feniralstat is a pyrazole analogue, a potent kallikrein inhibitor (antagonist) with IC50 of 6.7 nM for human plasma kallikrein (pKal).
Flizasertib V71869 Flizasertib 2268739-68-8 Flizasertib is a serine/threonine kinase inhibitor.
Fluorescent Substrate for Subtillsin V71893 Fluorescent Substrate for Subtillsin 147471-56-5 Fluorescent Substrate for Subtillsin may be utilized to detect the enzyme activity of Subtillsin.
Frovocimab (LY 3015014) V71862 Frovocimab (LY 3015014) 1643672-70-1 Frovocimab (LY 3015014) is a humanized IgG4 monoclonal antibody (mAb) that neutralizes PCSK9.
Galegenimab (FHTR 2163; RG 6147; RO 7171009) V73406 Galegenimab (FHTR 2163; RG 6147; RO 7171009) 2403683-24-7 Galegenimab (FHTR 2163; RG 6147; RO 7171009), an anti-HTRA1 antibody fragment.
GGACK V71909 GGACK 65113-67-9 GGACK (H-Glu-Gly-Arg-CMK) is an irreversible substrate-like inhibitor of the serine protease urokinase plasminogen activator (uPA).
HMB-Val-Ser-Leu-VE V71903 HMB-Val-Ser-Leu-VE 862891-04-1 HMB-Val-Ser-Leu-VE is a prototype vinyl ester vinyl ester inhibitor.
Inclisiran (ALN-PCSsc) V73397 Inclisiran (ALN-PCSsc) 1639324-58-5 Inclisiran (ALN-PCSsc) is a double-stranded small interfering RNA (siRNA) molecule that can inhibit PCSK-9 transcription.
Irucalantide V71859 Irucalantide 1631160-47-8 Irucalantide is a kallikrein inhibitor.
Lerodalcibep (LIB003) V71863 Lerodalcibep (LIB003) 2250073-78-8 Lerodalcibep (LIB003) is a recombinant fusion protein of PCSK9 binding domain (adnectin) and human serum albumin.
LSP-249 V5056 LSP-249 1801253-04-2 LSP-249 (example 35), information from patent WO2016011209A1, is an inhibitor (blocker/antagonist) of plasma kallikrein, utilized in study/research of angioedema, with EC50 of less than 100 nM.
Contact Us